Consistent with previous findings in HCC, CTNNB1 mutations are associated with an “immune-excluded” phenotype characterized by reduced infiltration of CD4+, CD8+ T cells, NK cells, and macrophages, leading to poor response to immune checkpoint inhibitors [31,32]. This evidence concerns the gene CD4 and hepatocellular carcinoma.